TIME to buy @1.35?....Have you prepare your bullets?

( Stock: [JTIASA]: JAYA TIASA HOLDINGS BHD
3 days ago | Report Abuse
Divergence of short term share price and cpo price is happening, Jtiasa may be testing support @ MAV20 near 1.35 to correct oversold technical before rebounding.)

Divergence of short term share price and cpo price is happening, Jtiasa may be testing support @ MAV20 near 1.35 to correct oversold technical before rebounding.

Divergence is happening, Taann wanted to test support to correct oversold technical.

GENP today ex 13 sen dividend will contribute to Genting coffer on 2-April

Jtiasa learn from Maybank action post dividen? Great....

Bull Bear struggling at 5.00. Who may win in March? I am not optimistic today because KLCI 1555 double tops shadow ..........but will close eye and hold till May 1st Q results to decide.

Uptrend declined. RM5 support still effective.......let stay a few day at 5

I am wrong again, mother lead son.....
(Today Son move mother?)

Today Son move mother?

Signal released.
MR CHUAH HOON PHONG 01-Mar-2024 Acquired 36,000 0.775
MR CHUAH AH BEE 01-Mar-2024 Acquired 36,000 0.775

I was wrong again, today is a hammer, if volume bigger, tomorrow GENM may state a breakout as MACD may cross signal, chances is high while share price above MAV20, RSI slightly above 50%, Stochastic already hooked up, - Mother Genting MACD crossed signal yesterday.
(Bet tomorrow a doji
22 hours ago)

Thanks Goldgent, this news change my view on TauRX HMTM (LMTM) to believe it may be approved in near term (may be 2025). Taiwan is traditionally supplier of US. if HMTM cannot be approved by US, although it may be approved by other countries, the value will be axed and the economy of scale may not be achieved .

(He forwarded this article for our reading 旭富觀音廠規劃2025年下半年投產
https://news.cnyes.com/news/id/5443124)

Genting unique way of testing support and resistance- it test from top to bottom. 4.95 and 5.02 tested ok d. it is may be also because too many investors trapped many years at the top from 1999-2023 at 4.90-5.40.

Local funds are struggling to start a Raya bull, hope it can reach 1570 which is a breakout of KLCI uptrend channel. if fail, double top of 1555 will bring KLCI to correct to 1490........

Hopefully a doji or a hammer today

Bet tomorrow a doji

Next resistance around 5.40. Holding power is the key. Actually it is insane to predict share prices.
If sentiment very strong and 5.37 can be crossed in 1st attempt, then potentially 5.37+0.72=6.09 as shown in the double swards video ; if can't, forming a flag again, if the flag is ranging from 5.40-5.05, then next target may be 5.05+0.72 =5.77, similar to target price of IB.
https://www.youtube.com/watch?v=dIazk_tO1D0

Malaysian palm oil futures were around MYR 4,090 per tonne after briefly hitting MYR 4,140 in the prior session, amid a further drop in crude oil prices and weakness in rival vegetable oils on the Chicago Board of Trade. Meanwhile, top buyer India's palm oil imports sank to a 9-month low in February as buyers reduced their palm oil orders to increase buying of sunflower oil. Still, the contracts remained near their highest level in over 7 months, with fresh data from the industry regulator indicating palm oil stocks at the end of February fell to their lowest level since July 2023 while production hit a 10-month low owing to unfavorable weather and a shortage of workers. At the same time, bets of robust demand sustained ahead of the Ramadan fasting month and Eid-al Fitr festival. On cargo surveyor data, shipments of Malaysian palm oil products for March 1-10 grew 6.2% to 325,543 tonnes from the same period in February, according to independent inspection company AmSpec Agri Malaysia.

Any pull back opportunity to buy. Washing Again........

Today released February total palm oil level is MoM lower at 1,919,210 tones vs January 2,020,191, drop by 5%,
https://bepi.mpob.gov.my/index.php/stock/313-stocks-2024/1173-monthly-closing-stock-of-oil-palm-products-2024

Dont worry Dompilee, Genting will reach your average cost this year, most probably this May results.

You are right neohts, GenB nothing to do with Taurx. However they have their own story. GENP up today because 13 sen dividen on the way and higher CPO price, GENM up because 9 sen dividen ahead and expected better profit 1stQ 24

Retest 5.11 support. Good

Bought GENM @2.90. A Technical signal buy appeared last Friday. GENM technical is not as strong as Genting but Genting surge too fast.
https://www.youtube.com/watch?v=aZZKycFZnbs

Half day break 2 resistances 5.02 and 5.11, next is 5.25. Good

Short term target around 5.40. Slow Slow will be better......
Checked Bursa Nett Short position no Genting share but only GENM.
(From Jan to March chart, Fund in control big wash weak holders 2 times and small wash numerous times, only push over RM5 at 3rd attempts. 3rd attempt is pushed only after hot money escaped with planned " disappointed" QR. Therefore 4.90-5 will be strong support for Genting share price.
After hitting 5.40, if share price can form a flag again, ranging 5.40-5 thus from 5+0.72=5.72 as next target.)
(Despite many times wrong prediction, technically we can see that Genting 1st leg is 4.74-4.02=0.72 (November 23), after that it enter less reliable flag pattern until MACD reaching neutral zone, stochastic reaching oversold zone yesterday. With today rebound, RSI hook up almost reaching 50% and Stochatic %K %D crossed smoothed %D. Again if 4.90 resistance can be crossed and stay more than 3 days, chances is 2nd leg 4.65+0.72=5.37 may be targeted. Any gap up above 5.40..........)

Confirmed breakout from 4.88 towards breakout of 5.02. Good

GENM also state a techinical buy signal as follows:
https://www.youtube.com/watch?v=aZZKycFZnbs
However Genting chart is technically more beautiful than GENM as long as Genting can stay above 4.88 these coming few days

Next week to support Bursa KLCI is expected to be Consumer (Genting), Finance and Plantation Index

US and Japanese market are expected to start a correction in 1-2 weeks time until a suitable timing for US to start an election bull run. Bursa is struggling to start a Raya bull but not sure if can be successful (if KLCI can be supported above 1520 by local fund). Genting technically is good at last Friday to start a short breakout because currently share price is above ceiling of long term downtrend channel @4.88 and also above MAV20. MACD hooked up from neutral touching signal but haven't crossed, Stochastic %K %D is above smooth %D and above 50%, RSI is @50%, hopefully tomorrow is at least a doji and closed above 4.88 then breakout can be maintained

Let's forget about TauRx, currently buy on pullback Genting for better YoY and QoQ of Revenue and profit 1stQ 24 Genting Singapore, better YoY and QoQ Revenue and profit 1stQ 24 Genting Malaysia, poorer YoY and QoQ of Revenue and profit 1stQ 24 Genting Plantation............

I am curious why today so many transections, so many sellers and buyers? Foreign fund is selling and local fund is buying?

Just checked there is no shortist, I thing most dare not short Genting as ii is traded at a huge discount to sons.
https://www.bursamalaysia.com/misc/missftp/sblnt/NetShortPosition20240307.pdf
( Posted by KooSan > 52 minutes ago | Report Abuse
Let's burn the shortist..)

Today rest, awaiting Monday February CPO stock level data

Today share price no bad, it let those purchase on 6 of March - 5.02 -4.82 (average transection price 4.90) to exit if they don't want to hold...........

Drug development is never been easy. Reaching Phase 3 is never easy.
 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210334/
Thirty‐seven new therapies—22 new chemical entities and 15 biologics—were approved by the FDA in 2022 across all therapeutic categories. 9 Five agents are active in the central nervous system (CNS) including one agent for relapsing multiple sclerosis, one treatment for amyotrophic lateral sclerosis, one anticonvulsant, and one therapy for the treatment of insomnia. One biological agent was directed at cerebral adrenoleukodystrophy to slow the progression of neurologic dysfunction. This is the smallest number of new drugs approved since 2016. There were no new treatments approved for AD in 2022. In 2021 and 2023, respectively, aducanumab and lecanemab received accelerated approval for the treatment of AD. Development for AD continues to be challenging with only these two drugs approved since 2003.

When people shouted all in, we started to be worrying......

1st target 1.47 reached. If advance a lot more, it will be a breakout of channel ceilling........
( 5 days ago | Report Abuse
Technically if you draw uptrend channel of Jtiasa, a few day back it drop below bottom channel at around 1.22, today with strong come back to the channel and you may see ceiling of the channel at around 1.47)

RM9+ is a dream now, will take long time to realize. Drug approval is a long process and affected by science, politics, international top fund interests.........

We may notice from 4.82 to 4.92 not much transections 3.4M, that means not much sellers d. Mostly hold to celebrate tomorrow

kokchengkai


Your analysis is logical, agreed. (Taurx present the data in Ad pd conference 2024 in portugal .. many bio medical company n Ad Pd reseacrh team will attend the conference . Don't worry only positive report wil b present if not they wil absent tht conference)

Wash again, today up, tomorrow depend on results if gap up or gap down?

Foreign hot fund is exiting Bursa.
https://www.bursamalaysia.com/bm/market_information/market_statistic/securities

Thank! ATK, you are really professional in Genting, need to learn from you. I am interested to hold at least till Genting Singapore 1st Q24 results, to decide if continue to hold

Of course medium term will swing upwards, expected a peak in 2026 VMY. Therefore my last add up 4.90 from 4.02 haven't sold yet. however if it gap up above 5.40 in this month will sell 50%

CPO future breakout from 4000, real resistance at 4200. GENP not moving yet but Jtiasa start last leg

ha, wash again. support at 4.80

From Jan to March chart, Fund in control big wash weak holders 2 times and small wash numerous times, only push over RM5 at 3rd attempts. 3rd attempt is pushed only after hot money escaped with planned " disappointed" QR. Therefore 4.90-5 will be strong support for Genting share price.
After hitting 5.40, if share price can form a flag again, ranging 5.40-5 thus from 5+0.72=5.72 as next target.
(Despite many times wrong prediction, technically we can see that Genting 1st leg is 4.74-4.02=0.72 (November 23), after that it enter less reliable flag pattern until MACD reaching neutral zone, stochastic reaching oversold zone yesterday. With today rebound, RSI hook up almost reaching 50% and Stochatic %K %D crossed smoothed %D. Again if 4.90 resistance can be crossed and stay more than 3 days, chances is 2nd leg 4.65+0.72=5.37 may be targeted. Any gap up above 5.40..........)

Despite many times wrong prediction, technically we can see that Genting 1st leg is 4.74-4.02=0.72 (November 23), after that it enter less reliable flag pattern until MACD reaching neutral zone, stochastic reaching oversold zone yesterday. With today rebound, RSI hook up almost reaching 50% and Stochatic %K %D crossed smoothed %D. Again if 4.90 resistance can be crossed and stay more than 3 days, chances is 2nd leg 4.65+0.72=5.37 may be targeted. Any gap up above 5.40..........

It seems that It is planned to use Genting to support KLCI @1425 a fews day........tricky

Presentataion in 2 days more, if every day up 0.10, may reach 4.99 on 7th..........